For as long as I can remember - we have been told that the oodles of cash spent accumulating data will be money well spent
There is growing global acceptance and interest in this space of MDMA treatments at the moment
it's gotta be now or never to monetise what we've been doing for 10yrs
or is EMD going to have just been a nice lifestyle provider for insiders for 10yrs
obviously there's no long term shareholders holding at the moment that have benefited
what is the future? It's hard to say its a buy right now
Add to My Watchlist
What is My Watchlist?
